S&P 500 7,758 +0.28% Nasdaq 26,585 -0.00% Dow Jones 54,034 -0.10% FTSE 100 10,862 -0.16% DAX 26,449 +0.94% Nikkei 225 66,970 +4.71% Hang Seng 25,653 -0.77% WTI Crude 82.22 +6.38% Gold 4,446 +4.80% US 10-Year Treasury Yield 4.682 +1.41% S&P 500 7,758 +0.28% Nasdaq 26,585 -0.00% Dow Jones 54,034 -0.10% FTSE 100 10,862 -0.16% DAX 26,449 +0.94% Nikkei 225 66,970 +4.71% Hang Seng 25,653 -0.77% WTI Crude 82.22 +6.38% Gold 4,446 +4.80% US 10-Year Treasury Yield 4.682 +1.41%

LATEST

eToro agrees to buy TradeZero for up to $231 million as equities drive Q2 growth●Suze Orman's retirement investing warning quietly returns●Polymarket makes moves to get house in order before expected boom times for prediction markets this fall●Sebi proposes wider FPI access to non-agri commodity derivatives●Latin America Needs Four Workers to Match One American, IDB Finds●Intel makes another $15 billion vital move as AI demand accelerates●Chile Wants Its Own Instant Payments — but Not a Central-Bank Pix●AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth●eToro agrees to buy TradeZero for up to $231 million as equities drive Q2 growth●Suze Orman's retirement investing warning quietly returns●Polymarket makes moves to get house in order before expected boom times for prediction markets this fall●Sebi proposes wider FPI access to non-agri commodity derivatives●Latin America Needs Four Workers to Match One American, IDB Finds●Intel makes another $15 billion vital move as AI demand accelerates●Chile Wants Its Own Instant Payments — but Not a Central-Bank Pix●AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth●

Companies

Sionna Therapeutics stock plunged 92% after its cystic fibrosis drug flopped in a mid-stage trial

Quartz · 1h ago

Sionna Therapeutics stock plunged 92% after its cystic fibrosis drug flopped in a mid-stage trial

The biotech said it will not advance SION-719 as an add-on therapy after the drug missed its key endpoint in a Phase 2a study

Read the full story at Quartz →

More Companies

Polymarket makes moves to get house in order before expected boom times for prediction markets this fall

Finance · 21m ago

Stocks opened slightly higher Tuesday as Nvidia rallied on a $500 billion AI infrastructure deal and oil prices held steady

Quartz · 46m ago

IBM and Together AI signed a $240 million open-source AI inference deal

Quartz · 54m ago

A startup founded by an xAI co-founder has raised $1.1 billion to build custom AI tools

Quartz · 57m ago